Table 2.
Demographic data of the 39 donors and recipients
| Characteristics* | AR group (N = 9) | Non-AR group (N = 30) | P† |
|---|---|---|---|
| Age at transplantation (yr) | |||
| Recipient | 49.0 (44.0–53.0) | 44.0 (36.0–54.0) | 0.385 |
| Donor | 47.0 (45.0–53.0) | 40.0 (33.0–49.0) | 0.054 |
| Sex | |||
| Female/Male | 2/7 (28.6%) | 9/21 (42.9%) | 0.595 |
| Body mass index (kg/m2) | |||
| Recipient | 22.4 (20.6–24.2) | 22.5 (18.7–25.9) | 0.958 |
| Donor | 22.3 (21.0–23.5) | 22.5 (20.4–24.7) | 0.741 |
| Allograft length (cm) | 10.5 (10.3–11.4) | 11.0 (10.3–11.3) | 0.446 |
| Donor type (living) | |||
| Genetically related | 2/9 (22.2%) | 22/30 (73.3%) | 0.001 |
| Parent | 0 | 12 | |
| Sibling | 2 | 10 | |
| Genetically unrelated (Spouse) | 7/9 (77.8%) | 8/30 (26.7%) | |
| Tacrolimus trough level (ng/mL) | 3.60 (3.10–4.85) | 4.73 (3.8–5.82) | 0.110 |
| ABO incompatibilities, N (%) (donor→recipient) | 1 (11.1%) | 10 (33.3%) | 0.421 |
| HLA mismatch (HLA-A, B, DR) | 5 (3–6) | 3 (2–4) | 0.044 |
| PRA Screening (%) (average) | 0.0 (0.0–0.0) | 0.0 (0.0–0.75) | 0.208 |
*All data are shown as median (IQR) unless otherwise indicated (i.e., N, %); †Significant P values are in bold.
Abbreviations: AR, acute rejection, including acute antibody-mediated rejection and T cell- mediated rejection; PRA, panel-reactive antibody; SD, standard deviation.